Insulin Exposure and Glucose Response to Meals in Type 1 Diabetic Subjects Administered Two Different Insulin Regimens Compared to the Endogenous Insulin Exposure and Glucose Response to Meals In Healthy Adult Controls

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

April 30, 2006

Study Completion Date

December 31, 2010

Conditions
Type 1 Diabetes
Interventions
DRUG

Insulin glulisine

Dose injection of insulin glargine (Lantus®) given subcutaneously in the abdomen 1 hour prior to breakfast and a dose of insulin glulisine (Apidra®) at a dose based upon your (body wt.) carbohydrate intake for each of the three meals (breakfast, lunch and dinner).

DRUG

Insulin

Dose based on carbohydrate intake given subcutaneously in the abdomen prior to breakfast and dinner.

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Vanderbilt University

OTHER